• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
Hansen Medical, Inc. develops, manufactures, and sells medical robotics designed for the positioning, manipulation, and control of catheters and catheter-based technologies in the United States and internationally.
Market Cap | 75.77 Million | Shares Outstanding | 18.99 Million | Avg 30-day Volume | 24.877 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -4.23 |
Price to Revenue | 3.7221 | Debt to Equity | -4.3745 | EBITDA | -37.746 Million |
Price to Book Value | 0.0 | Operating Margin | -276.44190000000003 | Enterprise Value | 70.883 Million |
Current Ratio | 0.616 | EPS Growth | -0.09 | Quick Ratio | 0.357 |
1 Yr BETA | 0.4213 | 52-week High/Low | 0.0 / | Profit Margin | -330.024 |
Operating Cash Flow Growth | 4.8572 | Free Cash Flow to Firm (FCFF) TTM | -41.647 Million | Free Cash Flow to Equity (FCFE) TTM | |
Altman Z-Score | -21.8764 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
No longer subject to file | 2016-07-27 | 0 | |
|
No longer subject to file | 2016-07-27 | 0 | |
|
No longer subject to file | 2016-07-27 | 0 | |
CATHCART ROBERT O SVP, GLOBAL SALES |
|
No longer subject to file | 2016-07-27 | 0 |
LOWE CHRISTOPHER P. INTERIM CFO |
|
No longer subject to file | 2016-07-27 | 0 |
|
No longer subject to file | 2016-07-27 | 0 | |
|
No longer subject to file | 2016-07-27 | 0 | |
|
No longer subject to file | 2016-07-27 | 0 | |
|
No longer subject to file | 2016-07-27 | 0 | |
|
No longer subject to file | 2016-07-27 | 0 | |
VANCE CARY GUY PRESIDENT AND CEO |
|
No longer subject to file | 2016-07-27 | 0 |
SHEAHAN BRIAN VP, REGULATORY, CLINICAL & QA |
|
No longer subject to file | 2016-07-27 | 0 |
GUIDO JOSEPH JAMES VP, MARKETING & BUSINESS DEV |
|
4,524 | 2016-02-12 | 0 |
|
0 | 2015-06-15 | 0 | |
|
49,096,207 | 2015-05-12 | 0 | |
|
23,612,250 | 2015-05-12 | 0 | |
SUTTON WILLIAM MITCHELL CHIEF OPERATING OFFICER |
|
0 | 2015-02-03 | 0 |
|
0 | 2014-04-29 | 0 | |
JACOB RITA V. VP TRAINING & CLINICAL AFFAIRS |
|
0 | 2014-03-03 | 0 |
LEONARD SUSAN VICE PRESIDENT, HUMAN RESOURCE |
|
0 | 2014-02-28 | 0 |
MARIANI PETER J CHIEF FINANCIAL OFFICER |
|
0 | 2014-02-25 | 0 |
|
211,286 | 2014-02-25 | 0 | |
|
528,706 | 2013-05-13 | 0 | |
BRUGUERA CAROLYN M VP, GENERAL COUNSEL |
|
9,110 | 2013-03-05 | 0 |
SCHEMBRI FRANK M. JR. VICE PRESIDENT MANUFACTURING |
|
7,092 | 2013-03-05 | 0 |
|
0 | 2012-05-25 | 0 | |
|
0 | 2012-05-25 | 0 | |
|
2,790,077 | 2012-03-01 | 0 | |
CHANG JEAN VICE PRESIDENT OF ENGINEERING |
|
15,724 | 2012-02-29 | 0 |
PEPLINSKI ROLAND GM EMEA & ASIA PACIFIC |
|
11,417 | 2012-02-29 | 0 |
MACKINNON MICHAEL T. VP U.S. COMMERCIAL OPERATIONS |
|
14,099 | 2012-02-29 | 0 |
MITTENDORFF ROBERT VP MARKETING & BUS DEV |
|
105,365 | 2011-12-15 | 0 |
HSIEH ARTHUR S. VICE PRESIDENT, LEGAL AFFAIRS |
|
21,305 | 2011-12-14 | 0 |
|
0 | 2011-06-15 | 0 | |
WALLACE DANIEL T. SVP & CHIEF TECHNOLOGY OFFICER |
|
138,404 | 2011-02-28 | 0 |
HUSTED KENNETH T. VP, US COMMERCIAL OPERATIONS |
|
100 | 2010-12-06 | 0 |
OSBORNE PETER INTERIM CFO |
|
0 | 2010-02-24 | 0 |
|
0 | 2009-06-17 | 0 | |
|
0 | 2009-06-17 | 0 | |
|
101,612 | 2009-05-11 | 0 | |
VAN DICK STEVEN M CFO, VP FINANCE AND ADMIN |
|
231,996 | 2009-04-16 | 0 |
SELLS CHRISTOPHER SR VP COMMERCIAL OPERATIONS |
|
0 | 2009-03-03 | 0 |
MURPHY M SEAN SR VP OPERATIONS |
|
2,269 | 2009-03-03 | 0 |
SHAW DAVID M SR VP BUS DEV, GENERAL COUNSEL |
|
45,000 | 2008-05-06 | 0 |
|
1,387,529 | 2007-11-02 | 0 | |
SKYLINE VENTURE PARTNERS QUALIFIED PURCHASER FUND III, L.P. SKYLINE VENTURE PARTNERS III, L.P. SKYLINE VENTURE MANAGEMENT III, LLC SKYLINE EXPANSION FUND MANAGEMENT, LLC |
|
1,935,562 | 2007-05-21 | 0 |
|
3,201,234 | 2006-11-21 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|
Holder | Issuer | Net Short Position | Position Date | Origin |
---|